Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aveo Pharmaceuticals Inc (NASDAQ:AVEO)

3.60
Delayed Data
As of Sep 22
 -0.115 / -3.10%
Today’s Change
0.50
Today|||52-Week Range
4.24
+566.67%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues1.3M18.1M19.0M2.5M
 
 
 
 
 
Depreciation And Amortization3.8M6.2M9.6M30.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses93.4M50.6M17.5M31.9M
 
 
 
 
 
Research And Development68.5M38.3M12.9M23.7M
 
 
 
 
 
Total Operating Expenses97.2M56.8M27.1M31.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-95.9M-38.7M-8.1M-29.4M
 
 
 
 
 
Extraordinary Credit0.00--6.4M4.8M
 
 
 
Extraordinary Charge-8.1M-11.7M-4.4M0.00
 
 
 
 
Interest Expense On Debt3.1M2.4M2.3M1.9M
 
 
 
 
 
Other Expenses-23.0K66.0K-6.7M-195.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-107.0M-52.7M-15.0M-26.8M
 
 
 
 
 
Income Taxes0.000.000.00-101.0K
 
 
Net Income-107.0M-52.7M-15.0M-26.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS50.9M52.3M55.7M69.3M
 
 
 
 
 
Shares To Calculate EPS Diluted50.9M52.3M55.7M69.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.10-$1.01-$0.27-$0.39
 
 
 
 
 
EPS Diluted-$2.10-$1.01-$0.27-$0.39